series-a
Stage
1
Investors
About
VedaBio develops a CRISPR-based molecular detection platform that enables ultra-rapid, amplification-free, and highly multiplexed nucleic acid detection for diagnostics applications.
Explore VedaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.